Characterization and expansion of mesenchymal progenitor cells from first-trimester chorionic villi of human placenta

References

• Jiang Y, Jahagirdar BN, Verfaillie C. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 2002; 418: 41–8
   PubMed Web of Science ®Google Scholar
• Minguell JJ, Erices A, Conget P. Mesenchymal stem cells. Exp Biol Med 2001; 226: 507–20
   PubMed Web of Science ®Google Scholar
• Pittenger MF, Mackay AM, Beck SC, et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999; 284: 143–7
   PubMed Web of Science ®Google Scholar
• Barry FP, Murphy JM. Mesenchymal stem cells: clinical applications and biological characterization. Int J Bioch Cell Biol 2004; 36: 568–84
   PubMed Web of Science ®Google Scholar
• Jorgensen C, Gordeladze J, Noel D. Tissue engineering through autologous mesenchymal stem cells. Curr Opin Biotechnol 2004; 15: 406–10
   PubMed Web of Science ®Google Scholar
• Lu H, Lu SF, Shen WY , et al. Successful combination therapy with infusion of allogenetic bone marrow mesenchymal stem cells and CAG regimen in hypoplastic relapsed acute myelogenous leukaemia. Leuk Res 2008;2–5.
   Google Scholar
• Mazzini L, Fagioli F, Boccaletti R. Stem cell therapy in amyotrophic lateral sclerosis: a methodological approach in humans. Amyotroph Lateral Scler Other Motor Neuron Disord 2003; 4: 158–61
   PubMed Web of Science ®Google Scholar
• Bieback K, Kern S, Kluter H, Eichler H. Critical parameters for the isolation of mesenchymal stem cells from umbilical cord blood. Stem Cells 2004; 22: 625–34
   PubMed Web of Science ®Google Scholar
• Guillot PV, Gotherstrom C, Chan J, et al. Human first-trimester fetal MSC express pluripotency markers and growth faster and have longer telomeres than adult MSC. Stem Cells 2007; 25: 646–54
   PubMed Web of Science ®Google Scholar
• Gonzalez R, Maki CB, Pacchiarotti J, et al. Pluripotent marker expression and differentiation of human second trimester mesenchymal stem cells. Biochem Biophys Res Commun 2007; 362: 491–7
   PubMedGoogle Scholar
• Igura K, Zhang X, Takahashi K, et al. Isolation and characterization of mesenchymal progenitor cells from chorionic villi of human placenta. Cytotherapy 2004; 6: 543–53
   PubMed Web of Science ®Google Scholar
• Lee OK, Kuo TK, Chen WM, et al. Isolation of multipotent mesenchymal stem cells from umbilical cord blood. Blood 2004; 103: 1669–75
   PubMed Web of Science ®Google Scholar
• Demir R, Kosanke G, Kohnen G, Kertschanska S. Classification of human placental stem villi: review of structural and functional aspects. Microscopy Res Tech 1997; 38: 29–41
   Web of Science ®Google Scholar
• Castellucci M, Scheper M, Scheffen I, et al. The development of the human placental villous tree. Anat Embriol 1990; 181: 117–28
   PubMedGoogle Scholar
• Fauza D. Amniotic fluid and placental stem cells. Best Prac Res 2004; 18: 877–91
   Google Scholar
• Kim J, Lee Y, Kim H, et al. Human amniotic fluid-derived stem cells have characteristics of multipotent stem cells. Cell Prolif 2007; 40: 75–90
   PubMed Web of Science ®Google Scholar
• Bossolasco P, Montemurro T, Cova L, et al. Molecular and phenotypic characterization of human amniotic fluid cells and their differentiation potential. Cell Res 2006; 16: 329–36
   PubMed Web of Science ®Google Scholar
• De Coppi P, Bartsch G, Siddiqui MM, et al. Isolation of amniotic stem cell lines with potential for therapy. Nature Biotechnol 2007; 25: 100–6
   PubMed Web of Science ®Google Scholar
• Pieternella S, Sherjon SA, Fibbe WE. Isolation of mesenchymal stem cells of fetal or maternal origin from human placenta. Stem Cells 2004; 22: 1338–45
   Google Scholar
• Kolf CM, Cho E, Tuan RS. Biology of adult mesenchymal stem cells: regulation of niche, self-renewal and differentiation. Arth Res Ther 2007; 9: 204–14
   PubMed Web of Science ®Google Scholar
• Portmann-Lanz CB, Schoeberlein A, Huber A, et al. Placental mesenchymal stem cells as potential autologous graft for pre- and perinatal neuroregeneration. Obstet Gynecol 2006; 194: 664–73
   Google Scholar
• Sessarego N, Parodi A, Podestà A, et al. Multipotent mesenchymal stromal cells from amniotic fluid: solid perspectives for clinical application. Hematologica 2008; 93: 339–46
   PubMedGoogle Scholar
• Colter DC, Class R, DiGirolamo CM, Prockop DJ. Rapid expansion of recycling stem cells in cultures of plastic-adherent cells from human bone marrow. PNSA 2000; 97: 3213–18
   PubMed Web of Science ®Google Scholar
• Javanoz EH, Beggs KJ, Flake AW. Mesenchymal stem cells: paradoxes of passaging. Exp Hematol 2004; 32: 414–25
   Google Scholar
• Sekiya I, Larson BL, Smith JR, et al. Expansion of human adult stem cells from bone marrow stroma: conditions that maximize the yields of early progenitors and evaluate their quality. Stem Cells 2002; 20: 530–41
   PubMed Web of Science ®Google Scholar
• Le Blanc K, Samuelsson H, Lonnies L, et al. Generation of immunosuppressive mesenchymal stem cells in allogeneic human serum. Transplantation 2007; 84: 1055–9
   PubMed Web of Science ®Google Scholar
• Shadadfar A, Fronsdal K, Haug T, et al. In vitro expansion of human mesenchymal stem cells: choice of serum is determinant of cell proliferation, differentiation, gene expression and trascriptome stability. Stem Cells 2005; 23: 1357–66
   Google Scholar
• Doucet C, Ernou I, Zhang Y, et al. Platelet lysates promote mesenchymal stem cell expansion: a safety substitute for animal serum in cell-based therapy applications. J Cell Physiol 2005; 205: 228–36
   PubMed Web of Science ®Google Scholar
• Bernardo ME, Avanzini MA, Perotti C, et al. Optimization of in vitro expansion of human multipotent mesenchymal stromal cells for cell-therapy approaches: further insights in the search for a fetal calf serum substitute. J Cell Physiol 2007; 211: 121–30
   PubMed Web of Science ®Google Scholar
• Kocaoemer A, Kern S, Kluter H, Bieback K. Human AB serum and thrombin-activated platelet-rich plasma are suitable alternatives to fetal calf serum for the expansion of mesenchymal stem cells from adipose tissue. Stem Cells 2007; 25: 1270–8
   PubMed Web of Science ®Google Scholar
• Gothersom C, Kingden O, Westgren M, et al. Immunomodulatory effects of human foetal liver-derived mesenchymal stem cell. Bone Marrow Transplant 2003; 32: 265–72
   Google Scholar
• Di Nicola M, Carlo-Stella C, Magni M, et al. Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or non-specific mitogenic stimuli. Blood 2002; 99: 3838–43
   PubMed Web of Science ®Google Scholar
• Le Blanc K, Tammik L, Sundberg B, et al. Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures and mitogenic responses independently of the major histocompatibility complex. Scand J Immunol 2003; 57: 11–20
   PubMed Web of Science ®Google Scholar
• Nasef A, Mathieu N, Chapel A, et al. Immunosuppressive effects of mesenchymal stem cell: involvement of HLA-G. Transplantation 2007; 84: 231–7
   PubMed Web of Science ®Google Scholar
• Rouas-Freiss N, LeMaoult J, Moreau P, et al. HLA-G in transplantation: a relevant molecule for inhibition of graft rejection?. Am J Transplant 2003; 3: 11–16
   Google Scholar